Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Eating disorder, Headache, Myalgia, Nausea
Clinical narrative: current age 9; Dose 1 15NoV2021; headache; high fevers; stomach upset; nausea; rash; unable to keep anything down; muscle aches; body aches; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the parent.  A 9 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 15Nov2021 12:30 (Batch/Lot number: unknown) at the age of 9 years as dose 1, single for covid-19 immunisation; influenza vaccine (INFLUENZA), administration date 15Nov2021 12:30 (Batch/Lot number: unknown). The patient had no relevant medical history. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 15Nov2021, outcome "recovering", described as "headache"; PYREXIA (non-serious) with onset 15Nov2021, outcome "recovering", described as "high fevers"; ABDOMINAL DISCOMFORT (non-serious) with onset 15Nov2021, outcome "recovering", described as "stomach upset"; NAUSEA (non-serious) with onset 15Nov2021, outcome "recovering", described as "nausea"; RASH (non-serious) with onset 15Nov2021, outcome "recovering", described as "rash"; EATING DISORDER (non-serious) with onset 15Nov2021, outcome "recovering", described as "unable to keep anything down"; MYALGIA (non-serious) with onset 15Nov2021, outcome "recovering", described as "muscle aches"; PAIN (non-serious) with onset 15Nov2021, outcome "recovering", described as "body aches"; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious) with onset 15Nov2021 12:30, outcome "unknown", described as "current age 9; Dose 1 15NoV2021". The events "headache", "high fevers", "stomach upset", "nausea", "rash", "unable to keep anything down", "muscle aches", "body aches" and "current age 9; dose 1 15nov2021" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of headache, pyrexia, abdominal discomfort, nausea, rash, eating disorder, myalgia, pain.  Clinical course: Started having high fevers, stomach upset, nausea, unable to keep any-thing down, rash, ongoing for 4 days. Also has muscle aches, body aches, headache. The patient did not receive treatment for adverse event. Covid prior vaccination was reported as 'No''. Covid tested post vaccination was reported as 'Yes''. Covid test post vaccination. Covid test type post vaccination=Nasal Swab, Covid test name post vaccination=Rt-PCR, covid test date=18Nov2021, Covid test result=Negative. Known allergies : No. Device timestamp 18Nov2021.  Additional information: Seriousness criteria-results in death: No. Seriousness criteria-life threatening: No. Seriousness criteria- caused/prolonged hospitalization: No. Seriousness criteria- disabling/incapacitating: No. Seriousness criteria-congenital anomaly/birth defect: No. Patient did not receive other vaccine in four weeks. Other medications in two weeks:  Received Flu vaccine at the same time.  The lot number for bnt162b2 was not provided and will be requested during follow up.